Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
Clinical trial NCT03203447 · TERMINATED
Trial details
- NCT number
- NCT03203447
- Sponsor
- Clearside Biomedical, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2018-12-18
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.